A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia

Relevant preclinical mouse models are crucial to screen new therapeutic agents for acute myeloid leukemia (AML). Current in vivo models based on the use of patient samples are not easy to establish and manipulate in the laboratory. Our objective was to develop robust xenograft models of human AML us...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Cancer J
Main Authors: Saland, E, Boutzen, H, Castellano, R, Pouyet, L, Griessinger, E, Larrue, C, de Toni, F, Scotland, S, David, M, Danet-Desnoyers, G, Vergez, F, Barreira, Y, Collette, Y, Récher, C, Sarry, J-E
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382660/
https://ncbi.nlm.nih.gov/pubmed/25794133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.19
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares